Lifevantage EBITDA Margin 2010-2024 | LFVN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Lifevantage (LFVN) over the last 10 years. The current EBITDA margin for Lifevantage as of September 30, 2024 is .
Lifevantage EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $0.20B $0.01B 5.10%
2024-06-30 $0.20B $0.01B 4.50%
2024-03-31 $0.21B $0.01B 4.39%
2023-12-31 $0.21B $0.01B 3.79%
2023-09-30 $0.21B $0.01B 3.76%
2023-06-30 $0.21B $0.01B 3.74%
2023-03-31 $0.21B $0.01B 2.37%
2022-12-31 $0.21B $0.01B 2.90%
2022-09-30 $0.21B $0.01B 3.41%
2022-06-30 $0.21B $0.01B 5.34%
2022-03-31 $0.21B $0.02B 8.57%
2021-12-31 $0.21B $0.02B 8.49%
2021-09-30 $0.22B $0.02B 10.96%
2021-06-30 $0.22B $0.02B 10.86%
2021-03-31 $0.23B $0.02B 10.67%
2020-12-31 $0.23B $0.03B 10.92%
2020-09-30 $0.23B $0.02B 9.96%
2020-06-30 $0.23B $0.02B 9.05%
2020-03-31 $0.23B $0.02B 8.30%
2019-12-31 $0.23B $0.02B 7.86%
2019-09-30 $0.23B $0.01B 6.19%
2019-06-30 $0.23B $0.01B 5.31%
2019-03-31 $0.22B $0.01B 4.91%
2018-12-31 $0.22B $0.01B 5.02%
2018-09-30 $0.21B $0.01B 6.19%
2018-06-30 $0.20B $0.01B 6.40%
2018-03-31 $0.20B $0.01B 5.00%
2017-12-31 $0.19B $0.01B 4.12%
2017-09-30 $0.19B $0.01B 3.09%
2017-06-30 $0.20B $0.01B 3.00%
2017-03-31 $0.20B $0.01B 4.46%
2016-12-31 $0.21B $0.01B 5.63%
2016-09-30 $0.22B $0.02B 6.94%
2016-06-30 $0.21B $0.02B 7.77%
2016-03-31 $0.20B $0.01B 6.57%
2015-12-31 $0.19B $0.01B 5.88%
2015-09-30 $0.18B $0.01B 6.01%
2015-06-30 $0.19B $0.02B 8.42%
2015-03-31 $0.20B $0.02B 9.45%
2014-12-31 $0.21B $0.02B 10.43%
2014-09-30 $0.22B $0.02B 11.16%
2014-06-30 $0.21B $0.02B 10.28%
2014-03-31 $0.21B $0.02B 8.57%
2013-12-31 $0.21B $0.02B 8.29%
2013-09-30 $0.21B $0.01B 5.83%
2013-06-30 $0.21B $0.01B 6.25%
2013-03-31 $0.20B $0.02B 9.95%
2012-12-31 $0.19B $0.02B 12.30%
2012-09-30 $0.16B $0.03B 16.35%
2012-06-30 $0.13B $0.02B 18.25%
2012-03-31 $0.10B $0.02B 17.71%
2011-12-31 $0.07B $0.01B 12.86%
2011-09-30 $0.05B $0.01B 13.46%
2011-06-30 $0.04B $0.00B 7.89%
2011-03-31 $0.03B 0 0.00%
2010-12-31 $0.02B 0 0.00%
2010-09-30 $0.02B $-0.00B -26.67%
2010-06-30 $0.01B $-0.01B -63.64%
2010-03-31 $0.01B $-0.01B -122.22%
2009-12-31 $0.01B $-0.01B -171.43%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.175B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Pro-Dex (PDEX) United States $0.140B 27.95